Skip to main content
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. — Investor Relations & Filings

Ticker · PPCB ISIN · US74346N4043 LEI · 549300Q3HY827FNV8Y56 US Professional, scientific and technical activities
Open in API
Filings indexed 412 across all filing types
Latest filing 2012-11-13 Regulatory Filings
Country US United States of America
Listing US PPCB

About Propanc Biopharma, Inc.

https://www.propanc.com/

Propanc Biopharma, Inc. is a clinical-stage company developing cancer treatments focused on preventing tumor recurrence and metastasis. Its lead candidate, PRP, is a pancreatic proenzyme formulation designed to target and eradicate cancer stem cells. The therapeutic approach aims to suppress tumor progression by controlling cancer cell migration, inhibiting the formation of tumor blood vessels, and inducing cell death. The company's primary focus is on developing long-term therapies for patients with solid tumors, such as pancreatic cancer.

Recent filings

Filing Released Lang Actions
NOTIFICATION OF LATE FILING
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company is unable to file its Form 10-Q quarterly report on time and requests additional time to file it. The document does not contain the actual financial data or the 10-Q report itself, but rather a notification about the delay in filing. According to the rules, such a notification is not the report itself but an announcement related to regulatory compliance. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories and includes officer certifications, attestations, and notifications of late filings.
2012-11-13 English
ANNUAL REPORT
Annual Report FY 2012
2012-10-15 English
LATE FILING NOTICE
Regulatory Filings Classification · 95% confidence The document is a Form 12b-25, which is a Notification of Late Filing for a Form 10-K annual report. It states that the company could not file its Form 10-K on time due to management not completing necessary adjustments. The document is short (4429 characters) and serves as a notification rather than the actual annual report. According to the 'MENU VS MEAL' rule, such a notification is an announcement about the report, not the report itself. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories.
2012-09-27 English
PRIMARY DOCUMENT
Director's Dealing
2012-08-24 English
PRIMARY DOCUMENT
Director's Dealing
2012-08-22 English
CURRENT REPORT
Board/Management Information Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated August 5, 2012. The content specifically reports the resignation of a director and chairman of the board, Dr. Douglas Mitchell, and notes the company's appreciation for his contributions. There is no financial data or detailed management discussion, but rather an announcement of a change in the company's board of directors. According to the filing definitions, announcements of changes in the company's board or senior management fall under Board/Management Information (MANG). The document length is short (2694 characters), consistent with a brief announcement rather than a full report. Therefore, the correct classification is MANG.
2012-08-13 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.